A randomized, double-blind, double-dummy trial comparing two once-daily regimens of edoxaban with warfarin in 21,105 patients with moderate-to-high-risk atrial fibrillation (median follow-up, 2.8 years).
JOURNAL ARTICLES ABOUT ANTICOAGULATION AND LIXIANA® (EDOXABAN) FROM PUBMED
Click on links below to access journal articles that may be of interest to you or a colleague, including the published clinical trials for LIXIANA® (edoxaban) from The New England Journal of Medicine.
By clicking on the links below, you will be redirected to respective journal article on PubMed. Click the back button on your browser to return to LIXIANA.com